News
News
Academy
Multimedia
Editorial Podcasts
Editorial Videos
Peer Exchange
Profiles in Medicine
Conferences
Conference Coverage
Conference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement Hubs
E-Books
Events
Sponsored Podcasts
Sponsored Videos
Webcasts
Whitepapers
Subscribe
News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe
Corporate Communications
Press Releases
Executive Roundtable
Executive Profiles
Leadership
Direct-to-Consumer
Patient Education
Healthcare Access
Telehealth
Emerging Biopharma
Partnerships
Funding
IR Licensing and Partnerships
Finance
Industry Trends
Market Access
Patient Access
Pricing
Strategy
Medical Affairs
Patient Advocacy
Clinical Data
Pharmacovigilance
Operations
Sustainability
Technology
R&D/Clinical Trials
Supply Chain
Patient Engagement
DE&I
Regulatory
FDA
Legal
Global
Sales & Marketing
Sales Effectiveness
Campaigns
DTC Marketing
Medical Education
Choose Topic
Spotlight -
Latest Executive Roundtables
|
Asembia 2025
|
Sales Effectiveness
Advertisement
Frank Saia
Advertisement
Articles by Frank Saia
AI and Social Listening: Myths vs. Facts
By
Frank Saia
August 11th 2020
What’s all the mystery about?
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments
2
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
3
The Real Value Equation: How Humans and AI Create and Destroy Value in Pharma
4
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
5
Pharmaceutical Executive Daily: Alnylam Invests $250 Million in Manufacturing Facility